“I’ve always seemed to fall into “Murphey’s Law” – if anything can go wrong, it will go wrong – which was my initial thought when I was diagnosed with Stage IV HER2+ breast cancer in my early thirties. Luckily through a clinical trial, we’ve found a way to keep my cancer at bay with minimal side effects so that I can continue raising my three boys, working and pursuing my artistic passions.”
About a year after Amanda gave birth to her third child, she noticed that her right breast was hard and sometimes hurt to touch, but she attributed the occasional pain to breastfeeding.
A few weeks later, a visible lump had formed, so Amanda immediately called her physician who referred her to a specialist. It was recommended that she have surgery to drain her milk ducts which appeared to be clogged, but during the operation, her surgeon decided to do a biopsy instead. Within a week, Amanda was diagnosed with Stage IV HER2+ breast cancer.
“When I was first diagnosed, my husband was luckily by my side. The news was shocking and my husband was very concerned. I let him worry enough for the both of us and just decided to throw my life in the hands of my doctors.”
Amanda began chemotherapy in April 2013 and had a double mastectomy in November 2014 before she was sent to Sarah Cannon Research Institute at Tennessee Oncology for a clinical trial. The clinical trial she was referred to was geared for women with metastatic cancer to keep the cancer from crossing the brain barrier.
Amanda has responded well to the combination of drugs that she received, which has kept her cancer from growing or spreading. Her hair is growing back, and her side effects are minimal– with some fatigue, nosebleeds and occasional neuropathy.
She enjoys time with her family and has picked back up her love of painting, sketching and drawing.
Read Amanda’s full story here.
Visit the Sarah Cannon website to learn more about clinical trials or call askSARAH at 844-482-4814.